AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05380011 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bimanual Task Training
Description: Bimanual Task Training will be performed. Bimanual Task Training has been shown to improve bimanual task performance, bilateral spontaneous use of affected limb and better bimanual coordination during daily life activities.
Study NCT05738473 — intervention group
Intervention type: DRUG
Intervention: antibiotic
Description: For pregnant women with GBS colonization, antibiotics are used to prevent infection
Study NCT05675878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: This is a whole food, nutrient-dense diet that aims to remove exposure to specific food additives thought to have negative neurological effects, while also optimizing micronutrient intake.
Study NCT05354011 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: Tape with a width of 5 cm and a thickness of 0.5 mm will be utilized. Kinesio Tex I Strip is estimated from elbow to fingertips and cut. It will be collapsed roughly two squares from the end and cut into two triangles on the overlay. The third and fourth fingers are fallen through openings and Kinesio Tex is applied on the dorsum of the hand with no strain. The situation of elbow extension, wrist extension, and radial deviation is given, and Kinesio Tex will be applied from hand to medial epicondyle with 15%-25% tension and end at medial epicondyle with no strain
Study NCT05354011 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Release Technique
Description: This group will receive Kinesiotaping with the same method along with Active release technique will be performed on group 2. We will apply profound tension at the region of tenderness while the patient is told to effectively move the injury site from a shortened to lengthened position. The setting of a contact point close to the injury and making the patient move in a way that creates a longitudinal sliding movement of delicate tissues e.g. nerves, ligaments and muscles underneath the contact point.
Study NCT04927286 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning to Breathe
Description: Learning to Breathe is an evidence-based mindfulness curriculum for adolescents
Study NCT04927286 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Campus Connections
Description: Campus Connections is a mentoring program for at-risk adolescents
Study NCT06433609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: Via intravenous infusion
Study NCT06433609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1921
Description: Via intravenous infusion
Study NCT06433609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Via intravenous infusion
Study NCT06392568 — intervention group
Intervention type: OTHER
Intervention: epidemiological records
Description: Healthcare associated infections due to emergent highly resistant bacteria, sites, risk factors, treatment and outcome
Study NCT05650801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Therapy using a traditional music originally from Indonesian culture
Study NCT06442579 — intervention group
Intervention type: OTHER
Intervention: Walking on a treadmill
Description: Participants have to walk without holding handrails and without bodyweight support for at least 200 gait cycles. They are asked to walk at comfortable walking speed while watching forward to a screen without virtual reality projection. Arm should be next to the body to allow arm swing if possible.
Study NCT05007951 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)
Description: injection volume of 0.5mL on days 0 and 28 (stage1)
Study NCT05007951 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ChAdOx1-S not less than 2.5 × 10^8 infectious units
Description: injection volume of 0.5mL on days 0 and 28 (stage1)
Study NCT05007951 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)
Description: injection volume of 0.5mL on days 0 (stage2)
Study NCT05007951 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)
Description: injection volume of 0.5mL on days 0 (stage2)
Study NCT05970900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib Mesylate
Description: 1. For patients with c-KIT exon 11 mutation, imatinib mesylate, 400mg, qd.~2. For patients with c-KIT exon 9 mutation, imatinib mesylate, 600mg or 800mg, qd.
Study NCT05970900 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local resection
Description: According to the characteristics of the location of the tumor, the surgeon decides the surgical approach based on the existing literature and the availability of surgical equipment, including:~1. Local transanal resection (TA)~2. Local resection transsacralapproach~3. Local resection via perineal approach~4. Local resection transvaginal approach
Study NCT05505162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zibotentan
Description: Participants will receive two capsules of Zibotentan orally QD from day 6-19.
Study NCT05505162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EE/LNG
Description: Participants will receive two tablets of EE and LNG once on Day 1 and Day 15 as a combined oral dose.
Study NCT05787873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIPS-2209-1
Description: QD, PO
Study NCT05787873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIPS-2209-2, SIPS-2209-3
Description: QD, PO
Study NCT05513937 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nebivolol
Description: Tablets administered orally once daily according instructions provided by Principal Investigator.
Study NCT05513937 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine
Description: Tablets of 5mg and 10mg administered orally once daily according instructions provided by Principal Investigator.
Study NCT05039450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EFX
Description: Investigational drug, Efruxifermin
Study NCT05039450 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05787080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: In the second hour of hemodialysis, vibration is applied to both calf muscles of the patients for 10 minutes three times a week for four weeks at low voltages.
Study NCT04966377 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS)
Description: Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS), increasing awareness of Syrian women under temporary protection against breast cancer, decreasing their perception of barriers to screening tests, developing early diagnosis behaviors (such as BSE, CBE and mammography), increasing their self-efficacy and breast cancer fears are expected to be reduced.
Study NCT06042153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Semaglutide will be injected into a skin fold, in the stomach, thigh or upper arm once a week at the same day of the week (to the extent possible) throughout the trial. Subjects will start semaglutide treatment at 0.25 mg; dose will gradually be increased every 4 weeks up to 1.0 mg.
Study NCT06042153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be injected into a skin fold, in the stomach, thigh or upper arm once a week at the same day of the week (to the extent possible) throughout the trial. Participants will receive placebo at an equivalent dose to semaglutide.
Study NCT06264882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Degarelix
Description: After first undergoing a pregnancy test, a clinician will administer an 80-mg subcutaneous injection of degarelix acetate (20 mg/mL; Ferring Pharmaceuticals Inc, Parsippany, NJ) to the women. A second injection will occur at 10 weeks. Compliance to the intervention will be ensured by having participants receive injections in the Clinical and Translational Research Center (CTRC), where all study visits will take place.
Study NCT06264882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal Estradiol Patch
Description: Treatment will be a weekly transdermal patch (0.075 mg) administered in a double-blinded manner. This estradiol dose increases serum estradiol to \~90 pg/mL. Compliance to the intervention will be monitored by having participants keep a log that tracks patch use.
Study NCT06264882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Transdermal Placebo Patch
Description: Treatment will be a weekly transdermal patch (placebo inactive) administered in a double-blinded manner. Compliance to the intervention will be monitored by having participants keep a log that tracks patch use.
Study NCT04818736 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccination
Description: Dose 1: 0.5 mL at Day 0 Dose 2: 0.5 mL at Day 28
Study NCT04818736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Participants can receive the COVID-19 whenever they are eligible according to local provincial guidelines.
Study NCT05771220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: radial extracorporeal shockwave therapy+ evidence-based physical therapy
Description: The experimental group received six sessions of rESWT over six weeks in addition to an EBPT program. The rESWT procedure involved applying shockwaves to the affected area using a radial probe, with sessions lasting 10-15 minutes and consisting of up to 2000 impulses delivered at a frequency of 3-6 pulses per second and an energy intensity level of 1.8 bar, based on patient tolerance. Patients were seated or lying down during the rESWT procedure, with gel or oil applied to facilitate shockwave transmission through the skin. Additionally, participants received a 30-minute exercise program twice a week for 6 weeks, which included hot packs, stretching, range of motion exercises, and isometric shoulder and scapular exercises. They were also instructed to perform the same exercises at home daily.
Study NCT05771220 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: sham radial extracorporeal shockwave therapy+ evidence-based physical therapy
Description: The participants in the control group received six weeks of sham rESWT (radial extracorporeal shock wave therapy) combined with the EBPT (evidence-based physical therapy) program. The sham rESWT involved six sessions with a maximum of 200 impulses delivered at a low intensity, with the applicator placed on the affected area for the same duration as the experimental group. Additionally, participants received a 30-minute exercise program twice a week for 6 weeks, which included hot packs, stretching, range of motion exercises, and isometric shoulder and scapular exercises. They were also instructed to perform the same exercises at home daily.
Study NCT04423874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cold pressor task (CPT)
Description: The cold pressor test is among the most common and established methods for studying human reactions to pain and pain tolerance.~Participants submerge a hand in cold water (approx. 5°C) and are asked to keep their hand submerged for as long as can (until the sensation is intolerable), up to a maximum of 5 min.~The procedure is safe because the hand is removed before adverse effects can occur.~The participant will be given a break of 5 min in between trials, and will interchange hands between trials.~During this break hand may to be place in warm water (25-35°C) for up to 4 min to normalise hand temperature, which will be measured before and after each trial using a digital thermometer held firmly in the palm of the hand. Each participant will complete no more than three trials (conditions) in a randomised order.
Study NCT04423874 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: index NOL
Description: Measurement of the index NOL™: Four sensors, placed non-invasively on one of the four participants' fingers, will make it possible to calculate a dozen physiological parameters converts in real time into a pain index called NOL (for Nociception Level Index).
Study NCT04423874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Playback Experiments
Description: During the experience, participants are led to listen, via headphones, to aversive non-verbal vocalizations (baby crying). The sound levels used to broadcast the non-verbal vocalisations will be scrupulously measured using approved and certified equipment during the preparation of the experiments. These sound volumes will be chosen so as not to inconvenience participants.
Study NCT04423874 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Video-pupillometry
Description: This technique is based on the observation of the dilatation of the pupil during the perception of a nociceptive stimulus in test persons.
Study NCT04703673 — intervention group
Intervention type: DRUG
Intervention: Cineole
Description: self administration according to directions for use
Study NCT04703673 — intervention group
Intervention type: DRUG
Intervention: Nasal Decongestant
Description: self administration according to directions for use
Study NCT05132842 — intervention group
Intervention type: OTHER
Intervention: Survey Administration
Description: Complete a Survey
Study NCT05192356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-348(3)
Description: QD, PO
Study NCT05192356 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-828, D097, D337
Description: QD, PO
Study NCT05743738 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Doppler ultrasound
Description: Control venous Doppler ultrasound
Study NCT06248281 — intervention group
Intervention type: OTHER
Intervention: combination of different rehabilitation strategies
Description: The psychoeducational program will be conducted through weekly online video-conferencing group sessions that will last for two hours. In addition to these sessions, participants will receive psychoeducational material such as readings, videos, podcasts, worksheets, and homework exercises every week. This material will allow participants to practice at their own pace during the session intervals.~The exercise training program for individuals with MS will be tailored to meet the unique and individual needs of each participant. To achieve this, a head and neck cooling protocol will be implemented using commercially available cooling equipment, specifically the Headcool Power and Neckcool Tie from Inuteq. Participants will need to wear the cooling cup and neck wrap for two hours daily. The equipment will be activated using 10°C tap water. Finally, a nutritionist will provide personalized nutritional guidance including weekly diet observation and recipe videos.
Study NCT05110703 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Supergut
Description: Meal replacement shake
Study NCT05110703 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05110703 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dietary guidelines
Description: Dietary guidelines
Study NCT05038020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AKST4290
Description: Oral AKST4290
Study NCT05038020 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Placebo
Study NCT05156970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab 200 mg IV on Day 1 of each 3-week cycle for up to 24 months
Study NCT05156970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 75 mg/m\^2 or Carboplatin AUC5 IV on Day 1 of each 3-week cycle (4 to 6 cycle maximum)
Study NCT05156970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel 75 mg/m\^2 IV on Day 1 of each 3-week cycle (4 to 6 cycle maximum)
Study NCT05156970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib Mesylate
Description: Apatinib 250mg qd for up to 24 months
Study NCT05156970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin at a target AUC 5 IV on Day 1 of each 3-week cycle (6 cycle maximum)
Study NCT05679128 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: identification of the cricothyroid membrane using Palpation
Description: identification of the cricothyroid using PALPATION, a procedure used to prepare for front of neck airway access
Study NCT05679128 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Identification of the cricothyroid membrane using ultrasonography
Description: identification of the cricothyroid membrane, using ULTRASONOGRAPHY, a procedure used to prepare for front of neck airway access
Study NCT05049096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: focused power ultrasound mediate inferior perirenal adipose tussue modification
Description: This novel focused power ultrasound is an externally delivered, completely noninvasive focused therapeutic ultrasound device. It is capable of focusing the resulting ultrasound beam to a small cigar-shaped volume and monitoring the temperature of the target area, which leads to the rapid elevation of the peri-renal adipose tissue temperature and the destruction of target tissue eventually.
Study NCT05049096 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham-control group
Description: participants will receive the sham control therapy(including peri-renal fat ultrasonic measurement and localization,focused ultrasound treatment parameters setting),however,without initiating the focused ultrasound equipment.
Study NCT05617833 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MLT+EPO
Description: Melatonin component will be a single daily dose of 30 mg/kg enteral administered in the evening. EPO component is a two-stage regimen with high dose EPO (1000 U/kg/dose q 48 hrs ± 2hr IV) for 10 doses followed by maintenance dose EPO (400 U/kg/dose q Monday, Wednesday, Friday IV/SC) to 33-6/7wk. Maintenance EPO dosing will begin on the day closest to completing the high dose series.
Study NCT05617833 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo enteral and IV
Study NCT05023356 — intervention group
Intervention type: DEVICE
Intervention: Non-contact vital signs monitoring with camera
Description: Monitor patients face image by non-contact vital signs monitoring with camera
Study NCT06353828 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD, synthetic form
Description: Cannabidiol enema
Study NCT06353828 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo enema
Study NCT05426889 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: subdural hematoma burr hole drainage
Description: For patients with larger hematoma, remove the hematoma by burr hole drainage
Study NCT05426889 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: drug conservative treatment
Description: The patient did not receive surgical treatment and chose conservative treatment
Study NCT05073497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Finger puppets
Description: In the experimental group, for distraction the researcher will put finger puppets consisting of various animal figures on his finger, and will ask the child to imitate these sounds by making animal-specific sounds that he moves with his finger. The researcher will also draw the child's attention to finger puppets by using methods such as making animals talk to each other and singing before and during venipuncture.
Study NCT06050174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azadirachta Indica
Description: Azadirachtaindica L. is a multipurpose medicinal tree of family Meliaceae.Is also named Nimba, holy tree, Vembu, Arishtha, Indian neem tree, Indian lilac, wonder tree. It occurs in tropical and semitropical regions of the world. Almost all parts of this incredible tree have been used as phytomedicines for more than 4,000 years.~Various pharmacological attributes such as antifungal, antiviral, antibacterial, anti-inflammatory, sterilant, antiscabic, antiallergenic and analgesic are attributed to various parts of the tree.
Study NCT06050174 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non Surgical Periodontal Therapy
Description: The patients will receive full mouth one stage debridement using ultrasonic scalers, manual scalers and curettes with oral hygiene instructions and education.
Study NCT06050174 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Non Surgical Periodontal Therapy
Description: The patients will receive full mouth one stage debridement using ultrasonic scalers, manual scalers and curettes with oral hygiene instructions and education.
Study NCT05347186 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systematic corrective exercises and non-biomechanical functional exercises
Description: 1. Restraint exercise or self-release: will involve the gastrocnemius muscle, soleus muscle, fibula, knee compressor muscles, adductors of the thighs, the short head of the biceps femoris, and iliotibial band for 30 seconds, using a foam roller.~2. Static stretching drills: involving the soleus and gastrocnemius muscles on an inclined plane, tensor fasciae latae muscle, short head of the biceps femoris, and ilio- psoas muscle;~3. Resistance exercises: will consist of strengthening the eccentric muscles of the feet including dorsiflexion and knee inversion, adduction, and extension, external rotation of the hip joint with TheraBand exercise band, and strengthening the intrinsic muscles of the foot.~4. Integrative exercises: including the star balance test on all planes and resistive exercises.